Veterinary Medicines

BIOCAN LR Λυοφιλοποιημένο υλικό και διαλύτης για ενέσιμο εναιώρημα

Authorised
  • Leptospira interrogans, serovar Grippotyphosa, Inactivated
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Rabies virus, Inactivated
Download as PDF

Product identification

Medicine name:
BIOCAN LR Λυοφιλοποιημένο υλικό και διαλύτης για ενέσιμο εναιώρημα
Active substance:
  • Leptospira interrogans, serovar Grippotyphosa, Inactivated
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Rabies virus, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serovar Grippotyphosa, Inactivated
    32.00
    log2 geometric mean titre
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
    32.00
    log2 geometric mean titre
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
    32.00
    log2 geometric mean titre
    /
    1.00
    Dose
  • Rabies virus, Inactivated
    2.00
    international unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 69253/19-06-2025/K-0267501
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 10/08/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 10/08/2023
Download